Clinical trial
Hemodynamic-GUIDEd Management of Heart Failure
NCT03387813 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT03387813 |
|---|---|
| Title | Hemodynamic-GUIDEd Management of Heart Failure |
| Official title | Hemodynamic-GUIDEd Management of Heart Failure |
| Acronym | GUIDE-HF |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure, Systolic, Diastolic, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV, Heart Failure，Congestive, Heart Failure With Reduced Ejection Fraction, Heart Failure With Normal Ejection Fraction, With Decompensation |
| Intervention type | Device |
| Interventions | CardioMEMS™ HF System |
| Enrollment | 2,358 |
| Start date | Mar 15, 2018 |
| Primary completion | May 17, 2023 |
| Completion | May 17, 2023 |
| First posted | Jan 2, 2018 |
| Last update posted | Aug 7, 2025 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: